ACTIVE SUBSTANCE / INN

DABRAFENIB MESYLATE

Brand name(s): TAFINLAR
FDA LISTED
PRESCRIPTION
NDA202806
ACTIVE SUBSTANCE
Dabrafenib Mesylate
REGULATORS
FDA
SPONSORS / MAH
NOVARTIS
TOTAL APPLICATIONS
1
FDA APPLICATIONS (DRUGS@FDA)
BRAND NAMEAPPLICATIONSPONSORSTATUS
TAFINLARNDA202806NOVARTISPrescription

FULL INTELLIGENCE ON DABRAFENIB MESYLATE

Patent cliffs, clinical trials, pipeline data, AI-enriched regulatory signals — free on PharmaSignal.

OPEN PLATFORM →